See the DrugPatentWatch profile for Fezolinetant
Is fezolinetant (Veozah) protected by a patent through 2026?
Public information on the exact patent-by-patent expiration date depends on the country and the specific patent(s) covering fezolinetant (for example, primary composition-of-matter, formulation, or method-of-use patents). With only the question provided, there isn’t enough detail to state whether “Fezolinetant Jimenez” has a patent that expires in 2026.
If you tell me the country (U.S., EU, UK, Canada, etc.) and whether you mean a specific company/patent (“Jimenez” could be a manufacturer, filer, or named inventor), I can help you pin down the likely patent families and their expiration windows.
When do patents for fezolinetant typically expire (and what affects the 2026 date)?
Even when a drug’s core patent is set to expire in a given year, the real end of market exclusivity can be later because of:
- Expiring patents that are tied to different claims (not all expire the same year).
- Regulatory exclusivities (which are often not the same as patent expiry).
- Patent terms that have been adjusted/extended under local rules.
- Additional patents filed later that extend protection for certain uses/formulations.
So a claim like “patent 2026” is only reliable when it’s tied to a specific patent number and jurisdiction.
How to check if a fezolinetant patent expires in 2026 (fast)
To verify whether protection ends in 2026, you typically need:
- The jurisdiction (U.S. vs. EU vs. UK, etc.).
- The patent identifier (number) or the patent family.
- The drug product label/brand and the assignee/manufacturer (to avoid mixing related compounds or different filers).
Common places to check:
- U.S.: FDA Orange Book (for U.S. listed patents and their expiry dates).
- EU/UK: national patent registers or Espacenet for the patent family, plus local regulatory exclusivity sources.
What I need from you to answer “2026” precisely
Reply with any of the following, and I’ll narrow it to the exact answer:
1) Country/jurisdiction (e.g., United States)
2) The patent number (if you have it)
3) What “Jimenez” refers to (company name, inventor, or patent assignee)
4) Brand name and product (fezolinetant/Veozah is typical—confirm)
Sources
None provided.